IEFM
BEAM icon

IQ EQ Fund Management’s Beam Therapeutics BEAM Stock Holding History

IQ EQ Fund Management’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.6M Sell
488,417
-45,146
-8% -$1.25M 0.88% 29
2025
Q4 		$14.8M Buy
533,563
+150,032
+39% +$3.83M 1.02% 24
2025
Q3 		$9.31M Buy
383,531
+188,243
+96% +$3.74M 0.63% 42
2025
Q2 		$3.32M Buy
195,288
+130,036
+199% +$2.26M 0.3% 94
2025
Q1 		$1.27M Buy
65,252
+33,054
+103% +$866K 0.15% 158
2024
Q4 		$799K Buy
32,198
+19,080
+145% +$487K 0.09% 209
2024
Q3 		$321K Buy
13,118
+3,815
+41% +$98.6K 0.03% 285
2024
Q2 		$218K Buy
+9,303
New +$228K 0.02% 289

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

IQ EQ Fund Management's BEAM Position: Q1 2026 in Review

IQ EQ Fund Management reduced its Beam Therapeutics (BEAM) stake by 8.5% in Q1 2026, selling an estimated $1.25M and leaving 488,417 shares worth $11.6M. The position accounts for 0.88% of the portfolio, ranked #29.

IQ EQ Fund Management first reported a position in BEAM in Q2 2024 and has held it in 8 quarters since. The position peaked at $14.8M in Q4 2025. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • IQ EQ Fund Management held 488,417 shares of Beam Therapeutics worth $11.6M as of Q1 2026.
  • IQ EQ Fund Management sold 45,146 Beam Therapeutics shares in Q1 2026, an estimated $1.25M.
  • Beam Therapeutics made up 0.88% of IQ EQ Fund Management's portfolio in Q1 2026, its #29 holding.
  • IQ EQ Fund Management first reported a position in Beam Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • IQ EQ Fund Management's Beam Therapeutics position peaked at $14.8M in Q4 2025.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on IQ EQ Fund Management's 13F filing for Q1 2026, filed 11 May 2026.